Table 4.
Male | Female | Total | P Value | |
---|---|---|---|---|
(n = 1,636) | (n = 556) | (N = 2,192) | ||
Age, y | 59.32 ± 0.73 | 50.71 ± 1.62 | 57.13 ± 0.71 | <0.001 |
Race and ethnicity | 0.008 | |||
White | 1,034 (65.99) | 254 (51.68) | 1,288 (62.57) | |
Black | 245 (15.62) | 160 (32.44) | 404 (19.64) | |
Hispanics | 155 (9.87) | 35 (7.12) | 190 (9.21) | |
Others | 133 (8.52) | 43 (8.76) | 177 (8.58) | |
Comorbidities | ||||
Chronic pulmonary disease | 364 (22.25) | 90 (16.17) | 454 (20.71) | 0.15 |
Atrial fibrillation | 567 (34.66) | 139 (24.99) | 706 (32.21) | 0.072 |
Diabetes mellitus | 477 (29.14) | 90 (16.20) | 567 (25.86) | 0.012 |
Hypertension | 992 (60.62) | 194 (34.90) | 1,186 (54.10) | <0.001 |
Obesity | 143 (8.75) | 60 (10.80) | 203 (9.27) | 0.51 |
Peripheral vascular disease | 295 (18.03) | 78 (14.06) | 373 (17.02) | 0.34 |
Renal failure | 711 (43.42) | 155 (27.82) | 865 (39.47) | 0.004 |
Liver disease | 443 (27.07) | 198 (35.68) | 641 (29.25) | 0.077 |
Dyslipidemia | 459 (28.04) | 100 (18.00) | 559 (25.50) | 0.046 |
Hypothyroidism | 113 (6.93) | 91 (16.30) | 204 (9.31) | 0.004 |
Valvular disease | 338 (20.63) | 151 (27.10) | 488 (22.27) | 0.20 |
Smoking | 245 (14.95) | 54 (9.78) | 299 (13.64) | 0.17 |
Alcohol abuse | 40 (2.44) | <11 cell count | 50 (2.29) | 0.72 |
Drug Abuse | 20 (1.22) | <11 cell count | 30 (1.37) | 0.65 |
Previous myocardial infarction | 229 (13.99) | 35 (6.30) | 264 (12.04) | 0.029 |
Previous CABG | 187 (11.46) | 34 (6.19) | 222 (10.12) | 0.087 |
Previous PCI | 160 (9.75) | 15 (2.70) | 175 (7.96) | 0.02 |
Values are mean ± SD or n (%) unless otherwise indicated. Significant values (P < 0.05) are indicated in bold.
CABG = coronary artery bypass graft.